ISO 11135-2014 PDF

Full title and description

ISO 11135:2014 — Sterilization of health-care products — Ethylene oxide — Requirements for the development, validation and routine control of a sterilization process for medical devices. This International Standard specifies requirements and guidance for establishing, validating and routinely controlling ethylene oxide (EO) sterilization processes for medical devices in both industrial and health-care facility settings, recognising differences in application and scale.

Abstract

ISO 11135:2014 defines the requirements for development, validation and routine control of ethylene oxide sterilization processes used to achieve and demonstrate the required sterility assurance for medical devices. It covers process design, biological and physical indicators, dose setting and verification, process parameters, documentation and release, as well as considerations for residues and aeration. The standard applies to both contract and in‑house sterilization operations and includes provisions relevant to industrial and health‑care facility applications.

General information

• Status: Published (current edition confirmed on review; includes a published amendment).
• Publication date: July 2014 (Edition 2, 2014).
• Publisher: International Organization for Standardization (ISO).
• ICS / categories: 11.080.01 (Sterilization of medical devices and health‑care products).
• Edition / version: Edition 2 (2014); ISO 11135:2014/Amd 1:2018 (Amendment 1 revising Annex E).
• Number of pages: 78 pages (main text of the 2014 edition).

Scope

The standard specifies requirements for the development, validation and routine control of ethylene oxide sterilization processes for medical devices. It covers selection of sterilization parameters and cycles, bioburden and biological indicator use, dose setting and verification, process monitoring and documentation, product and packaging considerations, residual EO and by‑product limits and aeration, and criteria for product release. It applies to industrial contract sterilizers and to sterilization performed within health‑care facilities where EO is used for medical devices.

Key topics and requirements

• Requirements for process development and qualification (validation) of EO sterilization cycles.
• Bioburden assessment and selection/use of biological indicators for validation and routine control.
• Dose setting, dose calculation and verification methods.
• Process monitoring parameters (temperature, humidity, gas concentration, exposure time) and instrumentation.
• Packaging, load configuration, and product compatibility considerations for EO exposure and aeration.
• Requirements for residual ethylene oxide and ethylene chlorohydrin/ethylene glycol by‑products and aeration protocols.
• Documentation, process change control, release criteria and records for routine control.
• Guidance on single‑batch release and related annex material (revised by Amendment 1:2018).

Typical use and users

ISO 11135:2014 is used by medical device manufacturers, contract sterilization providers, hospital sterile processing departments, regulatory and compliance engineers, quality/validation specialists and testing laboratories. It is referenced when designing and validating EO sterilization cycles, preparing validation protocols and reports, setting routine process controls, and establishing product release criteria and residual limits.

Related standards

Commonly referenced or complementary standards and guidance include ISO 11135:2014/Amd 1:2018 (amendment updating Annex E), ISO 11137 (radiation sterilization standards), ISO 17665 (moist heat sterilization standards), ISO 11737‑1/‑2 (methods for microbiological characterization and sterility testing), and a number of AAMI technical information reports and guidance documents that summarize or expand on ISO 11135 for U.S. practice (for example AAMI TIR74 and related TIRs). National and regional identical/adopted editions (EN ISO 11135:2014 and national adoptions) are also available.

Keywords

ethylene oxide, EO sterilization, sterilization validation, process development, dose setting, biological indicator, bioburden, aeration, residuals, sterility assurance level (SAL), medical devices, process monitoring, single‑batch release.

FAQ

Q: What is this standard?

A: ISO 11135:2014 is an international standard that specifies requirements for developing, validating and routinely controlling ethylene oxide sterilization processes used to sterilize medical devices.

Q: What does it cover?

A: It covers process design and validation, dose setting and verification, use of biological indicators and process monitors, packaging and load considerations, aeration and residual controls, documentation and release criteria for EO sterilization in both industrial and health‑care facility settings.

Q: Who typically uses it?

A: Medical device manufacturers, contract sterilizers, hospital sterile processing units, validation and quality professionals, test laboratories and regulatory authorities use the standard to demonstrate and maintain effective EO sterilization processes.

Q: Is it current or superseded?

A: The 2014 edition (Edition 2) with Amendment 1 (2018) is published and was reviewed and confirmed in ISO records (the edition remains current as published). A draft revision process has been recorded in ISO development pages at times, but the published 2014 edition with its amendment remains the current normative reference. Users should check their national adoption status and any later ISO updates before assuming newer revisions are in force.

Q: Is it part of a series?

A: Yes—ISO 11135 is part of ISO/TC 198’s family of sterilization standards and is related to other sterilization method standards (for example ISO 11137 for radiation, ISO 17665 for moist heat) and to microbiological standards such as ISO 11737. National or regional adoptions (EN ISO 11135) and industry guidance (AAMI TIRs) provide complementary material and change summaries.

Q: What are the key keywords?

A: ethylene oxide; EO sterilization; validation; dose setting; biological indicator; bioburden; aeration; residual ethylene oxide; sterility assurance level; medical devices.